CyTOF analysis of PBMCs following the 2016 seasonal influenza A vaccine revealed that patients with myeloproliferative neoplasms had reduced frequencies of central memory CD4+ and CD8+ T cells, total memory B cells, and resting memory B cells compared to healthy controls (HCs) three weeks post-vaccination [239]. This evidence concerns the gene CD4 and myeloproliferative neoplasm.